We analyzed the uptake and intracellular distribution of 12-5-labeled epidermal growth factor, nerve growth factor, and platelet-derived growth factor in different cell lines that express or do not express the respective surface receptors for these factors. After 1 hr of incubation, all three growth factors were detected in the cytoplasmic fraction and in the nucleus, tightly bound to chromatin. The amount of chromatin-bound growth factors continued to increase during the incubation, and analysis at 48 hr revealed each chromatinbound labeled growth factor in a nondegraded form. After limited digestion of chromatin with DNase 1 (10-20% digested sequences), specific release of all three growth factors was detected only after 1 hr of incubation but not after 24 and 48 hr, suggesting that the DNA regions involved in growth factor binding became nuclease-resistant. Binding of labeled epidermal growth factor and nerve growth factor to isolated chromatin was inhibited by monoclonal antibodies specific for the respective growth factor receptor. The data suggest that chromatin binding may represent an important step in the pathway of growth factor action.
binding became nuclease-resistant. Binding of labeled epidermal growth factor and nerve growth factor to isolated chromatin was inhibited by monoclonal antibodies specific for the respective growth factor receptor. The data suggest that chromatin binding may represent an important step in the pathway of growth factor action.
The precise mechanism by which different growth factors exert their effects is unclear, although interaction with the appropriate surface receptor and internalization (1) (2) (3) (4) (5) (6) (7) (8) (9) are common to all of these factors. The fate of internalized growth factors is controversial. Nerve growth factor (NGF) (10, 11) , epidermal growth factor (EGF) (12, 13) , and insulin (14) have been reported to accumulate in the nucleus. Binding of NGF to the chromatin of embryonic dorsal root neurons has been suggested by Andres and Bradshaw (11) . In contrast, Rohver et al. (9) have reported that nuclear accumulation of 125I-labeled NGF (125I-NGF) does not occur under physiological conditions.
In this report, we describe the binding of NGF, EGF, and platelet-derived growth factor (PDGF) to chromatin in cell lines expressing surface receptors for these factors. This binding is accompanied by a change in DNase II sensitivity at the growth factor-binding region of the chromatin.
MATERIALS AND METHODS
Cell Lines. Cells were grown in Eagle's minimal essential medium or Leibovitz's L-15 medium supplemented with 10% fetal bovine serum. Table 1 summarizes receptor expression in the cell lines used.
Monoclonal Antibodies (mAbs). Anti-NGF receptor mAb ME20.4 has been described (20) . Detailed characterization of anti-EGF receptor mAb 425, derived by immunization of mice with epidermoid carcinoma A431 cells, will be presented elsewhere. (6, 7) .
tHuman melanoma (15, 16) .
tLung carcinoma (17) . §Human colorectal carcinoma (18, 19 (24) . Cells were washed 3-5 times with PBS, disrupted in 0.35 M sucrose/10 mM KCl/1.5 mM MgCl2/10 mM Tris Cl, pH 7.6/0.12% Triton X-100/12 mM 2-mercaptoethanol and centrifuged at 600 x g for 10 min. The supernatant (crude cytoplasmic fraction) was centrifuged further for 1 hr at 105,000 x g to obtain the microsomal and pure cytoplasmic fractions. The nuclear pellet was washed first with 0.2 M sucrose/3 mM CaCl2/50 mM Tris Cl, pH 7.6, and then with 0.14 M NaCl/10 mM Tris Cl, pH 8.3, and centrifuged at 700
x g for 10 min. Nucleoplasmic proteins extracted with 0.14 M NaCl were defined as the "sap-protein" fraction. The
Abbreviations: NGF, nerve growth factor; PDGF, platelet-derived growth factor; EGF, epidermal growth factor; mAb, monoclonal antibody; 125I_, 125I-labeled. tTo whom reprint requests should be addressed.
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pellet was swelled in a small amount of 1 mM Tris Cl (pH 7.9). Chromatin was pelleted at the bottom of the tube, nucleoplasm (residual fraction after extraction with 0.14 M NaCl) was recovered from the top, and nuclear membranes were taken at the interface. Chromatin was further fractionated by extraction with 0.35 M and 2 M NaCl as described (25 Solid-Phase Radioimmunoassay. Chromatin was resuspended in 1 mM Tris Cl/1 mM EDTA at pH 7.4 and adsorbed to the wells of polyvinyl chloride microwell plates at 4°C, as described (27) , but without chromatin sonication. After the plates were washed with water and incubated with 1% bovine serum albumin in PBS to block nonspecific binding, they were incubated with mAb tissue culture supernatant (100 ,ul per well), washed, and incubated with '25I-labeled rabbit anti-mouse IgG, and bound radioactivity was measured.
Binding of '251-Labeled Growth Factors to Isolated Chromatin. Chromatin was adsorbed to the wells of microwell plates as described above. 1251I-EGF, -NGF, or -PDGF at concentrations from 0.1 to 40 ng/ml was added to each well and incubated for 2 hr at room temperature. After washing with PBS, bound radioactivity was measured. In competitive binding assays, chromatin adsorbed to the wells was incubated with unlabeled EGF (700 ng/ml), NGF (700 ng/ml), or PDGF (500 ng/ml), washed with PBS, and then incubated with the respective 111-labeled growth factor. In some experiments, anti-NGF receptor mAb ME20.4 or anti-EGF receptor mAb 425 was used instead of unlabeled growth factors.
Electrophoresis. Radiolabeled unbound and chromatinbound 12 I-labeled growth factors were analyzed by 0.1% NaDodSO4/15% PAGE (28). Gels were run at 100 V for 4 hr, stained with Coomassie blue, dried, and autoradiographed.
RESULTS

Uptake and Intracellular Distribution of 1251-EGF and 1251_
NGF. To determine whether intracellular uptake and chromatin binding of 125I-EGF and 125I-NGF is mediated by cell surface-bound receptors, we exposed cells expressing or not expressing receptors (Table 1) to these growth factors. In SW948 cells, which express EGF receptor but not NGF receptor, uptake of 125I-EGF was 40-to 100-fold higher than uptake of 1251-NGF and 150-fold higher than 125I-EGF uptake in EGF receptor-negative SW707 rectal carcinoma cells (Table 2 ). Uptake 1251-NGF by SW707 cells, which express NGF receptor, was 5-to 12-fold higher than uptake of '251-EGF by these cells. However, 125I-NGF uptake by Hs 294 melanoma cells, which overexpress NGF receptor, was 30-fold higher than that by SW707 cells.
More than 90% of 125I-EGF in SW948 cells was found in the cytoplasmic fraction throughout the incubation period ( Table  2 ). After 1 hr of incubation, a small amount (1.6%) of the 125I-EGF was chromatin-bound, which increased to 4.2% by 24 hr and 4.8% by 48 hr. Sap-protein and nucleoplasmic fractions also contained trace amounts of the 125I-EGF, as did the nuclear membranes.
The intracellular distribution of 125I-NGF differed in SW707 and Hs 294 cells (Table 2) . In SW707 cells, the greatest amount of 125I-NGF was detected in the cytoplasm after 1 hr of incubation, and this decreased after 24 hr and after 48 hr. The chromatin fraction, however, contained 20.5% ofthe 125I-NGF after 1 hr, which increased by 24 hr and 48 hr to -50%. The sap-protein and nucleoplasmic fractions contained a small amount of the 125I-NGF, and the least amount was in the nuclear membrane fraction. In Hs 294 melanoma cells, the cytoplasm also contained the highest amount of 125I-NGF during the first 24 hr of incubation, but tIncludes microsomal fraction, which contains up to 2% of the radioactivity. tUnlabeled NGF (500 ng/ml) was added 1 hr before 125I-NGF. §Cells were incubated for 1 hr with 125I-NGF (5 ng/ml), washed, and incubated for 24 hr in 125I-NGF-free medium.
Biochemistry: Rakowicz-Szulczynska et A (Table 2) . Similarly, unlabeled PDGF added at a 100-fold excess to WM 266-4 cells, inhibited uptake of 125I-PDGF by these cells by 80% (Table 3 ). In the presence of anti-PDGF antibodies, added to the incubation tIncludes microsomal fraction, which contains up to 3% Qf the radioactivity.
*Incubation in the presence of anti-PDGF antibodies. §Unlabeled PDGF (500 ng/ml) was added 1 hr before 1251-PDGF. (Table 3) .
Presence of 1251-Labeled Growth Factors in Chromatin
Fractions Obtained by Salt Extraction. To show that growth factors are tightly bound to chromatin and are not adsorbed to chromatin from the cytoplasm during the fractionation procedure, chromatin isolated from different cell lines (Table  4) 48 hr after incubation with the growth factor was extracted with 0.35 M and 2 M NaCl. Up to 80% of chromatin-bound 1251I-EGF, 75% of 125I-NGF, and 65% of 125I-PDGF were present in the residual chromatin fraction (Table 4) was isolated and treated with DNase II until a limit digest of 12-20% DNase II-sensitive sequences was obtained. Approximately 11-13% of the digested DNA was Mg2+-soluble (data not shown), which suggests that the digest obtained contains DNase II-sensitive, Mg2+-soluble, actively transcribed sequences that are preferentially digested (26) . Release of 125I-labeled growth factors during chromatin digestion was measured. After 1 hr of incubation with each of the three growth factors, digestion of =13% of DNA sequences released 70% of 125I-EGF (nonspecific release before digestion was -18%), 64% of 125I-NGF (nonspecific release 15%), and 50% of 125I-PDGF (nonspecific release 19%). After 24 hr of incubation, DNA digestion did not result in specific release of 125I-NGF and 125I-PDGF and released only 10% of 1251I EGF. After 48 hr, no specific release of any of the growth factors was detected (data not shown).
Binding of Anti-Growth Factor Receptor mAb to Isolated Chromatin. To determine whether binding of the growth factor to chromatin involves receptor-like molecules, binding of anti-NGF receptor mAb ME20.4 to chromatin adsorbed to microwell plates was studied (Fig. 2) . mAb ME20.4 bound to the microsomal fraction (used as control) and chromatin from Hs 294 melanoma cells, which express surface-bound NGF receptor, but not to chromatin from SW1116 colorectal carcinoma, which does not express NGF receptor. To exclude the possibility that mAb binding to the chromatin of Hs 294 cells reflects contamination with the NGF receptorcontaining microsomal fraction of these cells, the microsomal fraction was mixed with the nuclear pellet of SW1116 cells and chromatin was prepared as described in Materials and Methods. As shown in Fig. 2 , there was little difference in the binding of mAb to this preparation as compared to chromatin of SW1116 cells alone.
Binding of 125I-Labeled Growth Factors to Isolated Chromatin. Binding of '25I-EGF, -NGF, and -PDGF to chromatin of the appropriate cell line was inhibited 80-90% in the presence of the homologous unlabeled growth factor (Fig. 3) . Biochemistry: Rakowicz-Szulczynska et al.
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Biochemistry: Rakowicz-Szulczynska et al. B) and to SW707 chromatin, 50% in the presence of the same antibody (Fig. 3B) .
DISCUSSION
The results show that growth factors are taken up by cells into the cytoplasm and that some of the growth factor molecules become bound to the chromatin. In the case of EGF and NGF, uptake and subsequent binding to chromatin are associated with the presence of the appropriate receptors on the cell surface. For NGF, 84,000 molecules per nucleus (based on total incorporation, Table 2 ) were bound to the chromatin of Hs 294 cells, which expresses the highest number of cell surface NGF receptors (15) , as compared with 1800 molecules bound to chromatin of SW707 cells, which have low-level receptor expression (data not shown); NGF binding to chromatin of SW948 cells, which do not express receptors, was at background levels. For EGF, 7000 molecules were bound to the chromatin of receptor-expressing SW948 cells, whereas EGF binding to chromatin of SW707 cells, which do not express the receptor, was at background levels. PDGF, on the other hand, was bound to chromatin of both WM 266-4 and 1810 cells, neither of which expresses PDGF receptors (Table 3) . However, after a 1-hr exposure to 125I-PDGF at 5 ng/ml, two human fibroblast lines that express PDGF receptors took up more PDGF than did WM 266-4 and 1810 cells. Moreover, within 48 hr of exposure to PDGF, 1300 molecules were bound to chromatin per nucleus (based on total incorporation, At present, it is not known whether the growth factors exist in a free state or bound to the respective receptors. However, one suspects the presence of receptor-like molecules in the chromatin, since mAbs that react with either NGF or EGF receptors prevent binding of the corresponding growth factors to the chromatin. All three growth factors were recovered from the chromatin in a nondegraded state 48 hr after incubation. That the growth factors are tightly bound to chromatin and do not originate from the cytoplasmic fraction is indicated by the fact that up to 80% of the total chromatinbound growth factor was recovered from the residual chromatin fraction after extraction with 2 M NaCl. In addition, binding ofgrowth factors to specific DNase II-sensitive regions of chromatin eliminates the possibility that the binding sites are randomly distributed in the chromatin. These growth factorbinding regions were DNase II-sensitive after 1 hr of incubation but DNase II-resistant 24 hr later. A protective effect on isolated genes has been described (29, 30) .
Nuclear uptake of NGF (10, 11) and binding to the nuclear membrane (10) have been reported. Rohver et al. (9) reported that nuclear accumulation of 125I-NGF in PC12 cells occurred only when cells were maintained in 0.2% glucose/0.1% bovine serum albumin instead of culture medium; accumulation was observed only in plasma membranes and cytoplasm. In our hands, all three growth factors were directly bound to chromatin of several cell types grown under physiological conditions in culture medium. The mechanisms of nuclear uptake and binding to chromatin acceptor sites and the sequences possibly activated by different growth factors remain to be investigated.
